Document Detail

Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women.
MedLine Citation:
PMID:  20500110     Owner:  NLM     Status:  In-Data-Review    
Background and aim.?The effects of tibolone on cardiovascular risk is not yet fully understood today. We designed this study to assess the effect of the menopausal status and tibolone treatment (2.5?mg/day for 3 months) on different biomarkers of cardiovascular risk in healthy women. Methods.?Blood arterial pressure were measured, and blood samples collected for glucose, lipid profile (total cholesterol, high density lipoproteins, HDL, low density lipoproteins, and triglycerides), inflammatory (C-reactive protein, Interleukin-6, IL-6, tumor necrosis factor ?, TNF?) and oxidative stress (hydroperoxides and antioxidant capacity) evaluation in 15 premenopausal (mean age: 30???4 years) and 15 postmenopausal (mean age: 52???3, mean time from menopause 1.4???0.4 years) women before and after tibolone treatment. Results.?The menopausal status is associated with increased systolic and diastolic pressure (p?<?0.05), higher IL-6 (p?<?0.05) and TNF? (p?<?0.01), and lower antioxidants (p?<?0.01). However, blood pressure (p?<?0.05), glucose (p?<?0.05), TNF? (p?<?0.05) and HDL (p?<?0.05) fell after tibolone, which did not significantly affect levels of the other biochemical parameters. Conclusions.?As menopause is associated with increased blood pressure, inflammation and oxidative stress, tibolone restores blood pressure and has beneficial effect on inflammation and glycemia without worsening oxidative stress, although it also reduces HDL levels. Such modifications should be taken into account when tailoring menopausal therapies to specific requirements of each woman.
Cristina Vassalle; Ettore Cicinelli; Stefano Lello; Antonella Mercuri; Debora Battaglia; Silvia Maffei
Publication Detail:
Type:  Journal Article     Date:  2010-05-26
Journal Detail:
Title:  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology     Volume:  27     ISSN:  1473-0766     ISO Abbreviation:  Gynecol. Endocrinol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807913     Medline TA:  Gynecol Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  163-9     Citation Subset:  IM    
Fondazione G. Monasterio CNR-Regione Toscana and Institute of Clinical Physiology, CNR, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for ...
Next Document:  Metabolomics in serum of ovariectomised rats and those exposed to 17?-oestradiol and genistein.